Opthalmic compositions comprising F6H8

US11896559B2 · kind B2 · utility

Assignee

• NOVALIQ GMBH · DE

Inventors

• Bernhard Günther · Dossenheim, DE
• Frank LÖSCHER · Schriesheim, DE
• Hartmut Voss · Schriesheim, DE
• Sonja KRÖSSER · Heidelberg, DE
• Kirsten EICKHOFF · Aschaffenburg, DE
• Daniela WILLEN · Unter-Sensbach, DE
• Markus Beier · Heidelberg, DE
• Thomas Schlüter · Heidelberg, DE

Key dates

• Filing date: Oct 3, 2018
• Grant date: Feb 13, 2024
• Expiry date: Sep 13, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P27/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure provides methods of treatment using ophthalmic compositions comprising semifluorinated alkanes for keratoconjunctivitis sicca and/or Meibomian gland dysfunction, which methods provide for the enrichment of an ophthalmic tissue in the semifluorinated alkane, and optionally methods of delayed release of the semifluorinated alkane from the enriched ophthalmic tissue to the surface of the cornea and/or conjunctiva, and/or to the Meibomian gland.